Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 23, 2013
What's in a name? Intracranial peripheral primitive neuroectodermal tumors and CNS primitive neuroectodermal tumors are not the sameK Müller, B Diez, A Muggeri, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2017
Geographical variability in survival of European children with central nervous system tumoursG Gatta, R Peris-Bonet, O Visser, et al.
British Journal of Cancer|October 19, 2006
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomasS Wagner, M Benesch, F Berthold, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 6, 2021
Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry StudyD Jazmati, T Steinmeier, D Ahamd Khalil, et al.
Klinische Padiatrie|December 1, 2007
Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastomaM A Grotzer, K von Hoff, A O von Bueren, et al.
Oncogene|May 24, 2011
Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humansJ Pöschl, A Lorenz, W Hartmann, et al.
AJNR. American Journal of Neuroradiology|October 26, 2019
Imaging Characteristics of Wingless Pathway Subgroup Medulloblastomas: Results from the German HIT/SIOP-Trial CohortA Stock, M Mynarek, T Pietsch, et al.
Klinische Padiatrie|April 24, 2012
Targeted therapeutics in treatment of children and young adults with solid tumors: an expert survey and review of the literatureT G P Grunewald, N Greulich, U Kontny, et al.
British Journal of Cancer|September 15, 2012
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumoursA O von Bueren, M D Bacolod, C Hagel, et al.
British Journal of Cancer|October 13, 2004
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility studyS Rutkowski, S De Vleeschouwer, E Kaempgen, et al.
Pageof 8